Pancreatic ductal adenocarcinoma is one of the most lethal cancers, in large part because it usually stays hidden until it ...

Is the Galleri multi-cancer blood test worth it? A doctor explains real-world performance data and explains why no major ...

A new four-marker blood test accurately detects pancreatic cancer, including early stages, raising hopes for earlier diagnosis and improved survival pending further studies. Scientists backed by the ( ...

A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and ...

In 2026, an estimated 67,530 people will be diagnosed with pancreatic cancer, according to the American Cancer Society. But ...

A novel four-protein biomarker blood panel promotes early pancreatic cancer detection, identifying 91.9% of cancer cases and surpassing standard tests.

When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood ...

A new blood test could improve survival rates for pancreatic cancer – a disease which often tends to be diagnosed at later ...

Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic technologies promising improved survival rates.

National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal ...